An image guided treatment platform for prostate cancer photodynamic therapy

N. Betrouni; P. Colin; P. Puech; A. Villers; S. Mordon

doi:10.1109/EMBC.2013.6609514

An image guided treatment platform for prostate cancer photodynamic therapy

N. Betrouni
, P. Colin
, P. Puech
, A. Villers
, S. Mordon

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Scientific › peer-review

11 Citations (Scopus)

Abstract

This study describes a multimodality images based platform to drive photodynamic therapies of prostate cancer using WST 11 TOOKAD Soluble drug. The platform integrates a pre-treatment planning tool based on magnetic resonance imaging and a per-treatment guidance tool based on transrectal ultrasound images. Evaluation of the platform on clinical data showed that prediction of the therapy outcome was possible with an accuracy of 90 %.

Original language	English
Title of host publication	2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013
Pages	370-373
Number of pages	4
DOIs	https://doi.org/10.1109/EMBC.2013.6609514
Publication status	Published - 2013
Publication type	A4 Article in conference proceedings
Event	2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013 - Osaka, Japan Duration: 3 Jul 2013 → 7 Jul 2013

Conference

Conference	2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013
Country/Territory	Japan
City	Osaka
Period	3/07/13 → 7/07/13

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Computer Vision and Pattern Recognition
Signal Processing
Biomedical Engineering
Health Informatics

Access to Document

10.1109/EMBC.2013.6609514

Cite this

@inproceedings{36c7aeababd84a59bd012b11435269a0,

title = "An image guided treatment platform for prostate cancer photodynamic therapy",

abstract = "This study describes a multimodality images based platform to drive photodynamic therapies of prostate cancer using WST 11 TOOKAD Soluble drug. The platform integrates a pre-treatment planning tool based on magnetic resonance imaging and a per-treatment guidance tool based on transrectal ultrasound images. Evaluation of the platform on clinical data showed that prediction of the therapy outcome was possible with an accuracy of 90 \%.",

author = "N. Betrouni and P. Colin and P. Puech and A. Villers and S. Mordon",

year = "2013",

doi = "10.1109/EMBC.2013.6609514",

language = "English",

isbn = "9781457702167",

pages = "370--373",

booktitle = "2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013",

note = "2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013 ; Conference date: 03-07-2013 Through 07-07-2013",

}

Betrouni, N, Colin, P, Puech, P, Villers, A & Mordon, S 2013, An image guided treatment platform for prostate cancer photodynamic therapy. in 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013., 6609514, pp. 370-373, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013, Osaka, Japan, 3/07/13. https://doi.org/10.1109/EMBC.2013.6609514

An image guided treatment platform for prostate cancer photodynamic therapy. / Betrouni, N.; Colin, P.; Puech, P. et al.
2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013. 2013. p. 370-373 6609514.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Scientific › peer-review

TY - GEN

T1 - An image guided treatment platform for prostate cancer photodynamic therapy

AU - Betrouni, N.

AU - Colin, P.

AU - Puech, P.

AU - Villers, A.

AU - Mordon, S.

PY - 2013

Y1 - 2013

N2 - This study describes a multimodality images based platform to drive photodynamic therapies of prostate cancer using WST 11 TOOKAD Soluble drug. The platform integrates a pre-treatment planning tool based on magnetic resonance imaging and a per-treatment guidance tool based on transrectal ultrasound images. Evaluation of the platform on clinical data showed that prediction of the therapy outcome was possible with an accuracy of 90 %.

AB - This study describes a multimodality images based platform to drive photodynamic therapies of prostate cancer using WST 11 TOOKAD Soluble drug. The platform integrates a pre-treatment planning tool based on magnetic resonance imaging and a per-treatment guidance tool based on transrectal ultrasound images. Evaluation of the platform on clinical data showed that prediction of the therapy outcome was possible with an accuracy of 90 %.

UR - https://www.scopus.com/pages/publications/84886469344

U2 - 10.1109/EMBC.2013.6609514

DO - 10.1109/EMBC.2013.6609514

M3 - Conference contribution

AN - SCOPUS:84886469344

SN - 9781457702167

SP - 370

EP - 373

BT - 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013

T2 - 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2013

Y2 - 3 July 2013 through 7 July 2013

ER -

An image guided treatment platform for prostate cancer photodynamic therapy

Abstract

Conference

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this